Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience

INTRODUCTION: Bladder cancer is one of the most common malignancies worldwide. AIM: To analyse the influence of restaging transurethral resection of bladder tumour (reTURB) on outcomes in patients treated with BCG immunotherapy. MATERIAL AND METHODS: We analysed a database of 491 patients who were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewski, Wojciech, Zdrojowy, Romuald, Kościelska-Kasprzak, Katarzyna, Dembowski, Janusz, Wróbel, Michał, Łuczak, Mateusz, Kołodziej, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528127/
https://www.ncbi.nlm.nih.gov/pubmed/31118996
http://dx.doi.org/10.5114/wiitm.2018.79993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528127/
https://www.ncbi.nlm.nih.gov/pubmed/31118996
http://dx.doi.org/10.5114/wiitm.2018.79993

Ejemplares similares